# Application of the Workflow to Vericiguat

This folder contains all files related to the application of this workflow to vericiguat as previously published by Vrenken et al. [[1](#References),[2](#References)]. 

## Code of conduct
Everyone interacting in the Open Systems Pharmacology community (codebases, issue trackers, chat rooms, mailing lists etc...) is expected to follow the Open Systems Pharmacology [code of conduct](https://github.com/Open-Systems-Pharmacology/Suite/blob/master/CODE_OF_CONDUCT.md#contributor-covenant-code-of-conduct).

## Contribution
We encourage contribution to the Open Systems Pharmacology community. Before getting started please read the [contribution guidelines](https://github.com/Open-Systems-Pharmacology/Suite/blob/master/CONTRIBUTING.md#ways-to-contribute). If you are contributing code, please be familiar with the [coding standard](https://github.com/Open-Systems-Pharmacology/Suite/blob/master/CODING_STANDARDS.md#visual-studio-settings).

## License
The framework is distributed under the [GPLv2 License](https://github.com/Open-Systems-Pharmacology/Suite/blob/develop/LICENSE).

## References
[1] [Vrenken P, Vertzoni M, Frechen S, Solodenko J, Meyer M, Muenster U, Dallmann A. Development of a novel Physiologically Based Biopharmaceutics modeling (PBBM) framework using the Open Systems Pharmacology Suite, Part 1: in vitro modeling of Vericiguat. *Eur J Pharm Sci.* 2025 Jun 10;212:107164. doi: 10.1016/j.ejps.2025.107164. Epub ahead of print. PMID: 40505839](https://www.sciencedirect.com/science/article/pii/S0928098725001630)

[2] [Vrenken P, Vertzoni M, Frechen S, Solodenko J, Meyer M, Muenster U, Dallmann A. Development of a novel Physiologically Based Biopharmaceutics modeling (PBBM) framework using the Open Systems Pharmacology Suite, Part 2: in vivo pharmacokinetic modeling of vericiguat. Eur J Pharm Sci.* 2025 July 2; 107189. doi: 10.1016/j.ejps.2025.107189. Epub ahead of print.](https://www.sciencedirect.com/science/article/pii/S0928098725001885)
